채혈관 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the blood collection tubes market size in 2026 is estimated at USD 2.55 billion, growing from 2025 value of USD 2.39 billion with 2031 projections showing USD 3.54 billion, growing at 6.75% CAGR over 2026-2031.

This report is Segmented by Product Type (Serum-Separating Tubes, and More), Material (Plastic Tubes and Glass Tubes), Method (Vacuum Blood Collection Tubes and Non-Vacuum/Syringe-Based Tubes), Application (Diagnostics, and More), End-User (Hospitals & Clinics, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Blood Collection Tubes Market Trends and Insights

Growing Prevalence of Chronic Diseases

Rising incidences of diabetes, cardiovascular ailments, and cancer elevate routine monitoring needs, causing sustained uplift in tube volumes across hospital and outpatient sites. Aging populations in Europe and North America extend baseline demand, whereas emerging economies adopt guideline-based diagnostics that were previously scarce. WHO's patient-blood-management framework underscores reliable specimen quality as essential for anemia reduction and maternal-health programs. Novel tube chemistries that stabilize fragile biomarkers widen the testing menu for chronic-care pathways. As AI-driven platforms gain traction, early-stage detection expands, and high-quality tubes that guard analyte integrity become indispensable, thereby reinforcing the upward trajectory of the blood collection tubes market.

Expansion of Diagnostic Testing Volume

Post-pandemic reforms have permanently enlarged laboratory and point-of-care test menus. High-throughput panels now accompany annual wellness checks, chronic-disease reviews, and targeted screening, each requiring multiple tube types per encounter. Portable analyzers such as Truvian Health's benchtop unit deliver 98% agreement against core labs, pushing diagnostic reach into pharmacies and community clinics. Precision-medicine initiatives further intensify specimen complexity, as clinicians request biomarker suites that depend on tubes engineered for RNA, cfDNA, or trace elements. This escalating test intensity directly multiplies unit consumption, reinforcing the growth of the blood collection tubes market worldwide.

Risk of Infection from Improper Blood Handling

Occupational-safety agencies mandate sharps controls, yet uneven training raises exposure to needlestick injuries in resource-constrained hospitals. OSHA calls for puncture-proof containers and immediate disposal, adding operational cost. Extreme weather disrupted over 19,000 U.S. donations in 2024, revealing fragility in collection logistics that can escalate contamination risk. Meanwhile, the FDA increased surveillance on substandard plastic syringes, signaling tougher oversight that can delay product releases. Together, these factors temper market expansion where infrastructure and compliance budgets remain thin.

Other drivers and restraints analyzed in the detailed report include:

1. Technological Advancements in Vacuum Collection Systems
2. Rapid Growth of Point-of-Care Testing Market
3. Price Sensitivity and Reimbursement Constraints

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Serum-separating formats retained 38.12% share in 2025, anchored in routine chemistry panels across global labs. However, plasma-separating tubes will expand at 8.53% CAGR through 2031 on the back of regenerative-medicine protocols and cell-therapy workflows. Therapeutic applications claim 9.33% CAGR as platelet-rich plasma gains clinical favor for orthopedics and dermatology. Emerging ultrafiltration methods that enrich growth factors sharpen this demand curve and elevate the profile of specialized tubes within the blood collection tubes market.

Capillary micro-collection products are carving a niche in pediatric and point-of-care settings, buoyed by devices such as MiniDraw that reduce draw volumes without compromising analytical scope. EDTA tubes remain indispensable for hematology; rapid-serum variants fill emergency needs where turnaround time dictates clinical action. Collectively, these dynamics foster a balanced but growth-tilted portfolio, ensuring the segment contributes materially to overall blood collection tubes market growth.

Plastic retained 54.92% of the blood collection tubes market share in 2025 due to breakage resistance and lower cost. Yet glass tubes are slated for the fastest 8.63% CAGR, propelled by sustainability mandates and superior analyte stability in trace-element studies. The EU's Packaging and Packaging Waste Regulation compels recyclability by 2030, prompting R&D in hybrid tubes that fuse plastic robustness with glass-like vapor barriers.

Advanced chemo-PET variants now rival glass for chemical inertness while staying within biosafety guidelines, positioning them as a mid-transition solution. Recycling pilots in Denmark show promise for circular programs that may blunt regulatory penalties linked to single-use plastics. As these material shifts gain momentum, they reshape procurement criteria and reinforce the competitive stakes in the blood collection tubes market.

Complete Report Scope:

• By Product Type
  • Serum-Separating Tubes
  • EDTA Tubes
  • Plasma-Separating Tubes
  • Rapid Serum Tubes
  • Capillary Micro-Collection Tubes
  • Other Product Types
• By Material
  • Plastic Tubes
  • Glass Tubes
• By Method
  • Vacuum Blood Collection Tubes
  • Non-Vacuum / Syringe-Based Tubes
• By End-User
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Blood Banks & Transfusion Centers
  • Point-of-Care / Home-Care Settings
• By Application
  • Diagnostics
  • Therapeutics (Transfusion / Cell-therapy)
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America commanded 35.02% revenue share in 2025, a position underpinned by mature diagnostics infrastructure and early adoption of automation. The FDA's Quality Management System Regulation, effective 2026, harmonizes requirements with ISO 13485:2016 and simplifies device clearances, encouraging domestic production and exports. BD's pledge to invest USD 2.5 billion in U.S. capacity underscores confidence in steady regional demand. Weather-related donation shortfalls during 2024 spotlight resiliency gaps that may shape future infrastructure spending.

Asia-Pacific is projected to clock a 7.28% CAGR to 2031, powered by healthcare expansions under China's "Healthy China 2030" and India's widening lab networks. Terumo's USD 15 million localization spend demonstrates the pull of regional scale and regulatory incentives. Rising per-capita outlays and government focus on AI enable leapfrog adoption of advanced collection and testing systems, positioning the region as the dynamo of blood collection tubes market growth.

Europe holds a robust share, strengthened by policy leadership in sustainability. The Packaging and Packaging Waste Regulation catalyzes material innovation, and collaborative platelet-lysate standardization across EU centers ensures high-quality therapeutic inputs. The NHS target of 25% plasma self-sufficiency by 2025 signals dependable domestic uptake, whereas smaller Eastern European markets offer incremental gains as infrastructure modernizes. Collectively, these geographies forge a balanced demand mix that underpins the global blood collection tubes market's resilient outlook.

1. Beckton Dickinson
2. Greiner Bio One International
3. Terumo
4. Sarstedt
5. QIAGEN
6. F.L. Medical Srl
7. AdvaCare
8. Narang Medical
9. Hindustan Syringes & Medical Devices
10. DWK Life Sciences (Wheaton)
11. RAM Scientific Inc.
12. Nipro
13. Sekisui Medical Co., Ltd.
14. Medtronic
15. Danaher Corp. (Radiometer)
16. Cardinal Health
17. Shenzhen Kanghua Bio-medical (KHB)
18. Greiner AG Holding
19. BD Vacutainer Systems

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Prevalence of Chronic Diseases
  • 4.2.2 Expansion of Diagnostic Testing Volume
  • 4.2.3 Rising Surgical and Trauma Procedure Rates
  • 4.2.4 Increasing Government Blood Donation Initiatives
  • 4.2.5 Technological Advancements in Vacuum Collection Systems
  • 4.2.6 Rapid Growth of Point-Of-Care Testing Market
• 4.3 Market Restraints
  • 4.3.1 Risk of Infection From Improper Blood Handling
  • 4.3.2 Price Sensitivity and Reimbursement Constraints
  • 4.3.3 Regulatory Pressure on Single-Use Plastics
  • 4.3.4 Volatility in Raw Material Supply Chains
• 4.4 Regulatory Landscape
• 4.5 Porter's Five Forces Analysis
  • 4.5.1 Threat of New Entrants
  • 4.5.2 Bargaining Power of Buyers
  • 4.5.3 Bargaining Power of Suppliers
  • 4.5.4 Threat of Substitutes
  • 4.5.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Serum-Separating Tubes
  • 5.1.2 EDTA Tubes
  • 5.1.3 Plasma-Separating Tubes
  • 5.1.4 Rapid Serum Tubes
  • 5.1.5 Capillary Micro-Collection Tubes
  • 5.1.6 Other Product Types
• 5.2 By Material
  • 5.2.1 Plastic Tubes
  • 5.2.2 Glass Tubes
• 5.3 By Method
  • 5.3.1 Vacuum Blood Collection Tubes
  • 5.3.2 Non-Vacuum / Syringe-Based Tubes
• 5.4 By End-User
  • 5.4.1 Hospitals & Clinics
  • 5.4.2 Diagnostic Laboratories
  • 5.4.3 Blood Banks & Transfusion Centers
  • 5.4.4 Point-of-Care / Home-Care Settings
• 5.5 By Application
  • 5.5.1 Diagnostics
  • 5.5.2 Therapeutics (Transfusion / Cell-therapy)
• 5.6 Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East & Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East & Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
  • 6.3.1 Becton, Dickinson & Company
  • 6.3.2 Greiner Bio-One International GmbH
  • 6.3.3 Terumo Corporation
  • 6.3.4 Sarstedt AG & Co. KG
  • 6.3.5 Qiagen N.V.
  • 6.3.6 F.L. Medical Srl
  • 6.3.7 AdvaCare Pharma
  • 6.3.8 Narang Medical Limited
  • 6.3.9 Hindustan Syringes & Medical Devices Ltd
  • 6.3.10 DWK Life Sciences (Wheaton)
  • 6.3.11 RAM Scientific Inc.
  • 6.3.12 Nipro Medical Corporation
  • 6.3.13 Sekisui Medical Co., Ltd.
  • 6.3.14 Medtronic plc
  • 6.3.15 Danaher Corp. (Radiometer)
  • 6.3.16 Cardinal Health Inc.
  • 6.3.17 Shenzhen Kanghua Bio-medical (KHB)
  • 6.3.18 Greiner AG Holding
  • 6.3.19 BD Vacutainer Systems

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment